Tag

Drugpricing

All articles tagged with #drugpricing

health-and-policy2 years ago

"FDA Greenlights Florida's Initiative to Import Cost-Effective Canadian Drugs"

The FDA has approved Florida's plan to import prescription drugs from Canada, which is expected to lower medication costs. This marks a significant policy shift in the U.S. and aligns with bipartisan efforts to reduce drug prices. The program, backed by both President Biden and former President Trump, will be authorized for two years, with Florida required to test and relabel the drugs to meet U.S. standards. Canadian health providers have expressed concerns over the feasibility due to their own supply challenges. The pharmaceutical industry warns of potential risks to public health, and legal challenges are anticipated.

health-and-pharmaceuticals2 years ago

"Eli Lilly's New Weight Loss Drug Strategy Shakes Up Market, Despite Pushback on Cosmetic Use"

Eli Lilly has launched a new direct-to-consumer service, LillyDirect, offering telehealth prescriptions and home delivery for certain drugs, including the weight loss treatment Zepbound. This move, a first for a major drugmaker, aims to bypass traditional drug distribution systems and provide more accessible and transparent pricing. While it may not immediately disrupt the industry, it could lead to more pharmaceutical companies adopting similar models, increasing pressure on the current complex drug supply chain. Analysts believe that while the traditional infrastructure involving PBMs will remain, Eli Lilly's approach could streamline access to medications and potentially influence drug pricing and distribution practices.

health2 years ago

"Discontinuation of Popular Asthma Inhaler Raises Concerns for Patients and Providers"

Parents across the United States have been facing difficulties in obtaining a common asthma medication for their children due to changes in drug pricing. The medication, previously covered by insurance, is now not only uncovered but also at risk of being completely removed from the market. This situation has left many families in a challenging position to manage their children's asthma care.